These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8306496)

  • 81. Cellular pathway(s) of antigen processing and presentation in fish APC: endosomal involvement and cell-free antigen presentation.
    Vallejo AN; Miller NW; Harvey NE; Cuchens MA; Warr GW; Clem LW
    Dev Immunol; 1992; 3(1):51-65. PubMed ID: 1343103
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Editorial: Processing, presentation, and recognition of T cell determinants: From molecular insights to clinical applications.
    James EA
    Cell Immunol; 2023; 391-392():104756. PubMed ID: 37603955
    [No Abstract]   [Full Text] [Related]  

  • 83. New mechanism to promote long-term T-cell immunity by telomere transfer from antigen-presenting cells.
    Jin M; Huang JD
    Cell Mol Immunol; 2023 Feb; 20(2):117-118. PubMed ID: 36400982
    [No Abstract]   [Full Text] [Related]  

  • 84. A role for NADPH oxidase in antigen presentation.
    Gardiner GJ; Deffit SN; McLetchie S; Pérez L; Walline CC; Blum JS
    Front Immunol; 2013 Sep; 4():295. PubMed ID: 24069023
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cutting edge: NADPH oxidase modulates MHC class II antigen presentation by B cells.
    Crotzer VL; Matute JD; Arias AA; Zhao H; Quilliam LA; Dinauer MC; Blum JS
    J Immunol; 2012 Oct; 189(8):3800-4. PubMed ID: 22984083
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Ex vivo monitoring of antigen-specific CD4+ T cells after recall immunization with tetanus toxoid.
    Barbey C; Pradervand E; Barbier N; Spertini F
    Clin Vaccine Immunol; 2007 Sep; 14(9):1108-16. PubMed ID: 17634505
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Modulation by epitope-specific antibodies of class II MHC-restricted presentation of the tetanus toxin antigen.
    Watts C; Antoniou A; Manoury B; Hewitt EW; Mckay LM; Grayson L; Fairweather NF; Emsley P; Isaacs N; Simitsek PD
    Immunol Rev; 1998 Aug; 164():11-6. PubMed ID: 9795759
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cellular immunology of tetanus toxoid.
    Corradin G; Watts C
    Curr Top Microbiol Immunol; 1995; 195():77-87. PubMed ID: 8542760
    [No Abstract]   [Full Text] [Related]  

  • 89. Processing and presentation of tetanus toxin by antigen-presenting cells from patients with chronic granulomatous disease (CGD) to human specific T cell clones are not impaired.
    Barbey C; Tiercy JM; Fairweather N; Niemann H; Seger R; Corradin G
    Clin Exp Immunol; 1994 Feb; 95(2):227-31. PubMed ID: 8306496
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Processing of tetanus toxin by human antigen-presenting cells. Evidence for donor and epitope-specific processing pathways.
    Demotz S; Matricardi PM; Irle C; Panina P; Lanzavecchia A; Corradin G
    J Immunol; 1989 Dec; 143(12):3881-6. PubMed ID: 2480377
    [TBL] [Abstract][Full Text] [Related]  

  • 91. EBV transformed B cell lines present to antigen specific T cell clones determinants different from those recognized by antibody in an HLA-DR linked restricted fashion.
    Chu E; Umetsu D; Yunis E; Geha RS
    Hum Immunol; 1983 Nov; 8(3):217-26. PubMed ID: 6196340
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Modulation of antigen processing and presentation by covalently linked complement C3b fragment.
    Jacquier-Sarlin MR; Gabert FM; Villiers MB; Colomb MG
    Immunology; 1995 Jan; 84(1):164-70. PubMed ID: 7890301
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Antigen recognition by MHC-incompatible cells of a human mismatched chimera.
    Roncarolo MG; Yssel H; Touraine JL; Bacchetta R; Gebuhrer L; De Vries JE; Spits H
    J Exp Med; 1988 Dec; 168(6):2139-52. PubMed ID: 2462006
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Peptide-induced T cell clones: specificity, MHC restriction, proliferation and cytokine pattern as a function of different stimulations.
    Pichler WJ; Brander C; Mauri D; Frutig K; Wyss-Coray T
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):141-53; discussion 153-4. PubMed ID: 7873053
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A fatal granulomatous disease of childhood; the clinical, pathological, and laboratory features of a new syndrome.
    BRIDGES RA; BERENDES H; GOOD RA
    AMA J Dis Child; 1959 Apr; 97(4):387-408. PubMed ID: 13636694
    [No Abstract]   [Full Text] [Related]  

  • 96. The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86.
    Demotz S; Barbey C; Corradin G; Amoroso A; Lanzavecchia A
    Eur J Immunol; 1993 Feb; 23(2):425-32. PubMed ID: 7679644
    [TBL] [Abstract][Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.